Trial Profile
TCR Repertoire Analysis for Monitoring of Adult T-Cell Leukemia-Lymphoma Cells in Patients Receiving Mogamulizumab
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2020
Price :
$35
*
At a glance
- Drugs Mogamulizumab (Primary)
- Indications Adult T-cell leukaemia-lymphoma
- Focus Therapeutic Use